Haplogen's Grant

Haplogen raised a round of funding on September 11, 2018. Investors include FFG.

Haplogen is a privately held biotechnology company in Vienna, Austria, with drug discovery programs to combat viral infectious and other diseases. Haplogen was founded in 2010 as a spin-out of CeMM, t…

Articles about Haplogen's Grant: